Featured Research

from universities, journals, and other organizations

Researchers Develop First Way To Immunize Against A Deadly Bacterium

Date:
March 31, 1999
Source:
University Of California San Francisco
Summary:
Laboratory researchers have developed a new way to cripple a virulent class of microbes that have become increasingly resistant to antibiotics and continue to kill hundreds of thousands of hospital patients every year.

Laboratory researchers have developed a new way to cripple avirulent class of microbes that have become increasinglyresistant to antibiotics and continue to kill hundreds ofthousands of hospital patients every year.

The discovery, based on experiments with laboratory mice,provides immunization against the Pseudomonas aeruginosabacterium, suggesting a fresh alternative to antibiotics inthe fight against the microbes responsible for mosthospital-acquired pneumonia deaths. The bacteria kill halfthe hospital patients they infect.

The new finding led by scientists at the University ofCalifornia San Francisco and the Medical College ofWisconsin is reported in the April issue of Nature Medicine.A commentary on the research and its significance appears inthe same issue.

Nationally, more than two billion dollars a year are spentcombating hospital pneumonia, a condition most oftencontracted by patients already under intensive care.

The Pseudomonas species targeted in the research is alsoresponsible for the untreatable lung inflammations whichdevastate the lives of half a million people with cysticfibrosis. In addition, it belongs to the same group ofgram-negative bacteria as E. coli, Salmonella, and themicrobe responsible for plague, all of which may becandidates for the same immunization strategy developed bythe scientific team.

"All these species utilize the same combination of proteinsto deliver deadly toxins to host cells," says JeanineWiener-Kronish, MD, professor of anesthesiology and medicineUC San Francisco and one of the senior authors on the NatureMedicine paper. "We have developed an antibody against oneof these proteins and shown that it blocks Pseudomonas frominjecting toxins into lung cells. This antibody may wellprovide immunization against these other bacteria speciestoo."

Senior author on the Nature Medicine paper is Dara W. Frank,PhD, professor of microbiology and molecular genetics at theMedical College of Wisconsin. The collaboration involvedseven scientists from the two institutions, combining basicresearch in critical patient care and bacterial genetics todevelop the antibody and demonstrate its ability to provideimmunity against the Pseudomonas bacterium. First author onthe paper is Teiji Sawa, MD, PhD, adjunct assistantprofessor of anesthesiology at UCSF.

The bacterium employs what is known as a type III secretorysystem to infect lung cells. A combination of at least 25bacterial proteins work in concert to allow the microbeaccess to penetrate the outer surface of the host cell andinject toxins into it. The toxins are particularly difficultfor the cell to defend against, Wiener-Kronish explained,because they wipe out the primary line of defense -- themacrophages which would normally engulf such invaders.

The research team developed antibodies to five of theproteins in the bacterium's toxin delivery system and testedthe ability of each to block the deadly process. One of thefive, an antibody to the bacterium's PcrV antigen, preventedthe invading microbe from destroying the lung cellmacrophages. As a result, the cells could mount a defenseagainst the bacteria and prevent delivery of the toxin.Most importantly, lung cells were protected, the researchersreport.

The scientists do not yet know the precise role of thebacterial protein they have blocked. They know it is neededfor successful delivery -- or translocation -- of the toxinfrom the bacterium to the lung tissue, and that it itself isnot a toxin, they report.

Immunization could be useful not only against thePseudomonas-induced pneumonia, but also against thedevastating lung inflammations suffered by people withcystic fibrosis, says Wiener-Kronish. These same virulentbacteria cause the chronic inflammations of cystic fibrosis,and sufferers are never able to clear their lungs of themicrobes. A systemic approach such as immunization may holdmore promise than efforts at control through antibiotics,she says.

The bacteria also cause sepsis, or infection of the blood,by passing from the lungs into the bloodstream, and thescientists hope that sepsis too may be controlled throughantibody therapy.

The research group is now working with InterMunePharmaceutical, Inc. to develop an antibody therapy and avaccine for use in clinical trials with patients. Thescientists are also seeking to better understand how thebacterial type III secretory system works, expecting thatfurther refinements in the immunization strategy might bepossible.

"We're still in the development stages, but we think thatstudying PcrV may well reveal significant information aboutthe process of intoxication by type III systems," said DaraFrank of the Medical College of Wisconsin.

Collaborating in the research and on the paper with Sawa,Frank and Wiener-Kronish were Maria Ohara, MD, and KiyoyasuKurahashi MD, both Fellows in anesthesiology and MichaelGropper, MD, PhD, assistant professor of anesthesiology, allat UCSF, and Timothy L. Yahr, PhD, a postdoctoral scientistat Dartmouth Medical School. The research was funded by theNational Institutes of Health and the Cystic FibrosisFoundation.


Story Source:

The above story is based on materials provided by University Of California San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University Of California San Francisco. "Researchers Develop First Way To Immunize Against A Deadly Bacterium." ScienceDaily. ScienceDaily, 31 March 1999. <www.sciencedaily.com/releases/1999/03/990331063752.htm>.
University Of California San Francisco. (1999, March 31). Researchers Develop First Way To Immunize Against A Deadly Bacterium. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/1999/03/990331063752.htm
University Of California San Francisco. "Researchers Develop First Way To Immunize Against A Deadly Bacterium." ScienceDaily. www.sciencedaily.com/releases/1999/03/990331063752.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Newsy (July 30, 2014) The Peace Corps is one of several U.S.-based organizations to pull workers out of West Africa because of the Ebola outbreak. Video provided by Newsy
Powered by NewsLook.com
Weather Kills 2K A Year, But Storms Aren't The Main Offender

Weather Kills 2K A Year, But Storms Aren't The Main Offender

Newsy (July 30, 2014) Health officials say 2,000 deaths occur each year in the U.S. due to weather, but it's excessive heat and cold that claim the most lives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins